Progress in Eye Cancer Research
Ophthalmic cancer is any cancer that originates in the eye or its associated structures. It is a relatively rare form of cancer, accounting for less than 1% of all cancers. Ophthalmic cancer can affect the eyelid, conjunctiva, cornea, iris, ciliary body, choroid, retina, and optic nerve.
The most common type of ophthalmic cancer in adults is ocular melanoma, which typically starts in the cells that produce pigment in the eye. In children, retinoblastoma is the most common type of eye cancer arising from the cells of the retina.
The symptoms of ophthalmic cancer can vary depending on the location and stage of the malignancy. They may include:
- Vision changes or loss
- Eye pain or discomfort
- Redness or swelling of the eye
- Bulging or a mass on the eye
- Changes in the appearance of the eye, such as a change in colour or shape
- Floaters (spots or lines) in the field of vision
- Crossed or misaligned eyes (strabismus) in children
If ophthalmic cancer is suspected, an ophthalmologist or an oncologist (eye cancer treatment) will perform a thorough examination, which may include imaging tests such as ultrasound, MRI, or CT scans. Doctors perform a biopsy or fine-needle aspiration to obtain a small piece of the tumour for laboratory analysis. Treatment options for ophthalmic cancer depend on the type, size, location, stage of the cancer, and the patient's overall health.
They may include:
- Surgery: Surgeons perform a Surgical removal of the tumour. In some cases, the entire eye may need to be removed (enucleation).
- Radiation therapy: Surgeons use High-energy radiation to kill cancer cells or shrink tumours. It can be delivered externally (external beam radiation) or internally (brachytherapy) through a radioactive source implanted near the tumour.
- Laser therapy: Oncosurgeons use a focused light beam to destroy or shrink small tumours.
- Chemotherapy: Experts use medications to kill cancer cells or stop their growth. Chemotherapy may be delivered directly into the eye (intraocular chemotherapy).
- Targeted therapy: Doctors use drugs to target specific molecules or pathways involved in the growth of cancer cells.
- Immunotherapy: Surgeons use drugs to stimulate the immune system to recognise and destroy cancer cells.
It's important to note that treatment options and outcomes can vary widely depending on the specific type and stage of ophthalmic cancer. The prognosis for ophthalmic cancer also depends on factors such as the size of the tumour, its location, and whether it has spread to other parts of the body.
 |
| Ophthalmologist in cancer care clinic |
If you or someone you are acquainted with is dealing with a possible ophthalmic cancer diagnosis, you can seek advice from a medical specialist with expertise in treating eye cancer. This consultation will allow for a thorough discussion about the individual circumstances and the various available treatment options. The medical professional can offer personalised support and guidance throughout diagnosis and treatment. Eye cancers originate in the cells within the eyeball and adjacent structures, including the eyelids and tear ducts. These types of cancers are exceptionally uncommon. The prevalent forms encompass uveal melanomas, which develop in the uvea (the middle part of the eye), and retinoblastoma. Treatment options like brachytherapy, radiation therapy, and surgical interventions may be physible.
What are the types of eye cancer?
Eye cancer may occur in different parts of the eye or its associated structures.
Here are the most common types:
- Retinoblastoma is the most common eye cancer in children. It originates in the cells of the retina, the light-sensitive tissue at the back of the eye.
- Uveal Melanoma: This type of cancer starts in the melanocytes, the pigment-producing eye cells. It commonly affects the choroid (the layer of blood vessels beneath the retina) but can also occur in the iris or ciliary body.
- Conjunctival Melanoma: It begins in the conjunctiva, the thin membrane of the white part of the eye, and lines the inside of the eyelids.
- Eyelid Cancer: There are different types of eyelid cancer, including basal cell carcinoma, squamous cell carcinoma, and sebaceous gland carcinoma. These cancers typically develop on the eyelid skin.
- Lacrimal Gland Tumors: These tumours originate in the lacrimal gland, which produces tears. They can be benign or malignant.
- Ocular Lymphoma: Ocular Lymphoma is a rare type of eye cancer that affects the lymphocytes, a type of white blood cell. Ocular lymphoma can occur in the eye or as secondary cancer spreading from other body parts.
- Rhabdomyosarcoma: This is rare cancer that primarily affects children and arises from the muscles that control eye movement.
It's important to note that these are just some common types of eye cancer and other rare types. The specific treatment and prognosis for each type of eye cancer can vary, so it's crucial to consult with a medical professional in eye cancer for an accurate diagnosis and appropriate management.
What are the recent developments in the treatment of eye cancer?
We can provide information about some notable developments up until that time. It's vital to consult with a medical professional for the latest updates. Here are a few noteworthy developments in eye cancer treatment:
- Targeted Therapies: Doctors explore targeted therapies as a treatment option for certain types of eye cancer. These therapies aim to inhibit specific molecules or pathways in cancer growth to disrupt tumour growth and survival.
- Immunotherapy: Immunotherapy has shown promise in treating some eye cancers. It involves using drugs that stimulate the body's immune system to recognize and attack cancer cells. Immune checkpoint inhibitors, such as pembrolizumab and nivolumab, have been investigated for metastatic uveal melanoma.
- Intra-arterial Chemotherapy: Intra-arterial chemotherapy involves delivering chemotherapy drugs directly into the blood vessels that supply the eye. This technique allows for the targeted delivery of higher drug concentrations while minimizing systemic side effects. Doctors use it in retinoblastoma, particularly for cases resistant to treatments.
- Proton Beam Therapy: Proton beam therapy is a type of radiation therapy that uses protons instead of X-rays to deliver radiation to the tumour. Surgeons use it for certain eye cancers, such as uveal melanoma and retinoblastoma. Proton beam therapy offers more precise targeting therapy in reducing radiation exposure to surrounding healthy tissues.
- Genetic Testing and Precision Medicine: Advances in genetic testing have provided insights into the molecular characteristics of eye cancers. This information can help identify specific genetic mutations or alterations that may guide treatment decisions. Precision medicine approaches aim to tailor treatments based on an individual's genetic profile to enhance efficacy and minimize side effects.
It's important to note that research and developments in eye cancer treatment continue to evolve. New treatment options may emerge, and clinical trials may uncover promising therapies. Consulting with an ophthalmologist or an oncologist specializing in eye cancer will provide the most up-to-date information on recent advancements and potential treatment options for specific cases.
What is the most common form of eye cancer?
Ocular melanoma is the most common form of eye cancer in adults. It typically originates from the melanocytes, the pigment-producing cells in the eye. Ocular melanoma primarily affects the uveal tract, which consists of the choroid, ciliary body, and iris. The choroid is the most frequent site of occurrence for ocular melanoma. However, it's important to note that eye cancers, including ocular melanoma, are relatively rare compared to other cancers.
 |
| Happy Eye Cancer Patient |
What causes eye cancer?
The exact causes of eye cancer are not fully understood. Certain risk factors increase the likelihood of developing eye cancer.
These risk factors include:
- Age: Eye cancers, such as ocular melanoma and retinoblastoma, can occur at any age, but they are frequent in adults or young children.
- Hereditary Factors: Certain genetic conditions can increase the risk of developing eye cancer. Specific genetic mutations that can be inherited are associated with retinoblastoma.
- Ultraviolet (UV) Radiation: Prolonged and excessive exposure to UV radiation, such as from sunlight or tanning beds, has been linked to an increased risk of ocular melanoma.
- Light Eye Color: People with light-coloured blue eyes or green shades may have a slightly higher risk of developing ocular melanoma than those with darker eye colours.
- Fair Skin: Individuals with fair skin, who are more prone to sunburn, may have a higher risk of developing ocular melanoma.
- Occupational Exposure: Prolonged exposure to certain chemicals and substances, such as asbestos, may increase the risk of developing eye cancer.
- History of Radiation: Previous radiation treatment, especially to the head and neck area, can raise the risk of developing eye cancer later in life.
It's important to note that having one or more of these risk factors does not necessarily mean a person will develop eye cancer. Many people with eye cancer have no identifiable risk factors, and individuals with these risk factors do not develop the disease. If you have concerns about eye cancer or any risk factors you may have, you must consult with a medical professional for a thorough evaluation and personalized guidance.